{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:33:50Z","timestamp":1793093630490,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.114021","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T13:56:35Z","timestamp":1638280595000},"page":"114021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects"],"prefix":"10.1016","volume":"228","author":[{"given":"Noha M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-6928","authenticated-orcid":false,"given":"Samar H.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awatef E.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan H.","family":"Georgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114021_bib1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2021.114021_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tim.2013.12.007","article-title":"Overcoming the current deadlock in antibiotic research","volume":"22","author":"Sch\u00e4berle","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2021.114021_bib4","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.0800944105","article-title":"Drug interactions modulate the potential for evolution of resistance","volume":"105","author":"Michel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.114021_bib5","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2021.114021_bib6","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmc.2017.02.068","article-title":"Covalently linked kanamycin \u2013 ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance","volume":"25","author":"Shavit","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib7","first-page":"2144","article-title":"Design , microwave-assisted and conventional synthesis of new hybrid compounds derived from 1- ( 4-Fluorophenyl ) piperazine and screening for their biological activities","volume":"3","author":"Ozdemir","year":"2018","journal-title":"Chem. Sel."},{"key":"10.1016\/j.ejmech.2021.114021_bib8","first-page":"385","article-title":"Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation Dnyaneshwar","volume":"5","author":"Sarkar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib9","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.bmcl.2017.06.009","article-title":"Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV q","volume":"27","author":"Mitton-fry","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.114021_bib10","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1128\/AAC.01649-07","article-title":"In\u00a0vitro evaluation of CBR-2092, a novel Rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus","volume":"52","author":"Robertson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib11","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1351\/pac200779122143","article-title":"Some approaches to new antibacterial agents","volume":"79","author":"Bremner","year":"2007","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/17460441.2010.508069","article-title":"Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance","volume":"5","author":"Pokrovskaya","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114021_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib14","doi-asserted-by":"crossref","first-page":"115439","DOI":"10.1016\/j.bmc.2020.115439","article-title":"Identification of an ethyl 5,6-dihydropyrazolo[1,5-c]quinazoline-1-carboxylate as a catalytic inhibitor of DNA gyrase","volume":"28","author":"Aguirre","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11164-018-3598-3","article-title":"New ciprofloxacin\u2013dithiocarbamate\u2013benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies","volume":"45","author":"Esfahani","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2021.114021_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluoroquinolone-isatin hybrids and their biological activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA gyrase: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.114021_bib18","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.114021_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2013.06.045","article-title":"Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activities","volume":"67","author":"Mentese","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cbdd.12395","article-title":"Design, synthesis, antibacterial evaluation and docking study of novel 2-hydroxy-3-(nitroimidazolyl)-propyl-derived quinolone","volume":"85","author":"Li","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.114021_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1099\/00222615-44-5-320","article-title":"Quinolones: structure-activity relationships and future predictions","volume":"44","author":"Tillotson","year":"1996","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ejmech.2021.114021_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00002018-199513060-00004","article-title":"Tolerability of fluoroquinolone antibiotics","volume":"13","author":"Ball","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejmech.2021.114021_bib23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jhet.3234","article-title":"Quinolone-Triazole hybrids and their biological activities","volume":"55","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2012.01.060","article-title":"Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold","volume":"50","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib25","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3390\/molecules25122946","article-title":"Hybrid quinoline-sulfonamide complexes (M2+) derivatives with antimicrobial activity","volume":"25","author":"Diaconu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.114021_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejmech.2004.11.008","article-title":"Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies","volume":"40","author":"Nieto","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ejmech.2008.09.012","article-title":"Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids","volume":"44","author":"Jazayeri","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/AAC.44.2.320-325.2000","article-title":"Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase","volume":"44","author":"Alovero","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib29","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/AAC.46.8.2498-2506.2002","article-title":"Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones","volume":"46","author":"Pan","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib30","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.3390\/molecules13102557","article-title":"Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives","volume":"13","author":"Georgey","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.114021_bib31","series-title":"Foye's Principles of Medicinal Chemistry","author":"Lemke","year":"2012"},{"key":"10.1016\/j.ejmech.2021.114021_bib32","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.37.9.1764","article-title":"Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice","volume":"37","author":"Akahane","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib33","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1007\/s00044-014-0977-1","article-title":"Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl) hydrazine","volume":"23","author":"Al-wabli","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.114021_bib34","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.3390\/molecules24173130","article-title":"Antibacterial evaluation, in silico characters and molecular docking of schiff bases derived from 5-aminopyrazoles","volume":"24","author":"Hassan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.114021_bib35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1107\/S2059798316001212","article-title":"Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex","volume":"72","author":"Veselkov","year":"2016","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.114021_bib36","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1294\/5\/052033","article-title":"New azo-azomethine derivative of sulfanilamide: synthesis, characterization, spectroscopic, antimicrobial and antioxidant activity study","volume":"1294","author":"Al-Atbi","year":"2019","journal-title":"J.\u00a0Phys. Conf. Ser."},{"key":"10.1016\/j.ejmech.2021.114021_bib37","doi-asserted-by":"crossref","first-page":"103642","DOI":"10.1016\/j.bioorg.2020.103642","article-title":"Synthesis of sulpha drug based hydroxytriazene derivatives: anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies","volume":"96","author":"Sharma","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib38","first-page":"881","article-title":"Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties., Iran","volume":"13","author":"Saeedi","year":"2014","journal-title":"J.\u00a0Pharm. Res. IJPR."},{"key":"10.1016\/j.ejmech.2021.114021_bib39","article-title":"Design, synthesis and pharmacological evaluation of sulfanilamide-ciprofloxacin conjugates utilizing hybridization approach as new antibacterial agents","volume":"5","author":"Mohammed","year":"2015","journal-title":"J.\u00a0Nat. Sci. Res."},{"key":"10.1016\/j.ejmech.2021.114021_bib40","first-page":"206","article-title":"Synthesis, characterization and study biological activity of some new pyrimidine and 1, 2, 3, 4-tetrazole derivatives based on sulfadiazine","volume":"9","author":"Abbass","year":"2016","journal-title":"Int. J. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.114021_bib41","first-page":"2055","article-title":"Synthesis and Antibacterial activity of Chloroacetyl derivatives of some Schiff bases","volume":"17","author":"Husain","year":"2005","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib42","first-page":"3108","article-title":"Synthesis and antitumor screening of some novel pyrrolo, pyrrolo[2,3-d]pyrimidinone and pyrrolo[2,3-b] pyridinone derivatives of sulfaquinoxaline","volume":"9","author":"Taha","year":"2013","journal-title":"Appl. Sci. Res."},{"key":"10.1016\/j.ejmech.2021.114021_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.15227\/orgsyn.079.0186","article-title":"Preparation of secondary amines from primary amines via 2-nitrobenzenesulfonamides: N-(4-Methoxybenzyl)-3-Phenylpropylamine: benzenepropanamine, N-[(4-methoxyphenyl)methyl]-","volume":"79","author":"Kurosawa","year":"2002","journal-title":"Org. Synth."},{"key":"10.1016\/j.ejmech.2021.114021_bib44","doi-asserted-by":"crossref","first-page":"o1559","DOI":"10.1107\/S1600536810020465","article-title":"3-Chloro- N -(4-sulfamoylphenyl)propanamide","volume":"66","author":"Akkurt","year":"2010","journal-title":"Acta Crystallogr. Sect. E Struct. Reports Online."},{"key":"10.1016\/j.ejmech.2021.114021_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2014.08.016","article-title":"Improvement of antibacterial activity of some sulfa drugs through linkage to certain phthalazin-1(2H)-one scaffolds","volume":"85","author":"Ibrahim","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114021_bib46","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/jac\/dkr247","article-title":"Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics","volume":"66","author":"Alt","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.114021_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkl504","article-title":"High-throughput assays for DNA gyrase and other topoisomerases","volume":"34","author":"Maxwell","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.114021_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2021.114021_bib49","first-page":"1","article-title":"Synthesis and biological evaluation of new pyridothienopyrimidine derivatives as antibacterial agents and Escherichia coli topoisomerase II inhibitors","volume":"9","author":"El-Deen","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2021.114021_bib50","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically ; Approved Standard \u2014","author":"Wayne","year":"1997"},{"key":"10.1016\/j.ejmech.2021.114021_bib51","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1515\/CCLM.2007.342","article-title":"Differential expression of \u03b3-aminobutyric acid receptor A (GABA A) and effects of homocysteine","volume":"45","author":"Tyagi","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ejmech.2021.114021_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biochi.2019.02.002","article-title":"The C7-aminomethylpyrrolidine group rescues the activity of a thio-fluoroquinolone","volume":"160","author":"Lentz","year":"2019","journal-title":"Biochimie"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:28Z","timestamp":1759329148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"alternative-id":["S0223523421008709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114021","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114021"}}